Incannex Healthcare (IXHL) Operating Expenses (2022 - 2026)
Incannex Healthcare's (IXHL) quarterly Operating Expenses came in at $4.0 million in Q1 2026, down 19.09% year-over-year from $5.0 million in Q1 2025, and down 42.13% quarter-over-quarter from $7.0 million in Q4 2025.
Analysis
Incannex Healthcare (IXHL) Operating Expenses (2022 - 2026) Analysis & Trends
Incannex Healthcare has disclosed Operating Expenses across 5 years of filings, most recently posting $4.0 million for Q1 2026.
- In Q1 2026, Operating Expenses fell 19.09% year-over-year to $4.0 million; the TTM figure through Mar 2026 stood at $25.4 million (down 2.83% YoY), while the FY2025 annual figure was $23.9 million, down 20.56% from the prior year.
- Operating Expenses came in at $4.0 million for Q1 2026 at Incannex Healthcare, down from $7.0 million in the prior quarter.
- In the past five years, Operating Expenses ranged from a high of $9.8 million in Q2 2024 to a low of $3.6 million in Q4 2022.
- Average Operating Expenses over 5 years is $5.9 million, with a median of $5.7 million recorded in 2024.
- The largest YoY upside for Operating Expenses was 132.62% in 2024 against a maximum downside of 37.17% in 2024.
- Over 5 years, Operating Expenses stood at $3.6 million in 2022, then jumped by 119.37% to $8.0 million in 2023, then sank by 37.17% to $5.0 million in 2024, then surged by 39.45% to $7.0 million in 2025, then sank by 42.13% to $4.0 million in 2026.
- Per Business Quant data, the three most recent Operating Expenses figures were $4.0 million in Q1 2026, $7.0 million in Q4 2025, and $6.8 million in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 643.46 Bn | 622.70 Bn | 17.26 Bn | 10.12 Bn |
| 2 | AbbVie | 440.39 Bn | 433.82 Bn | 12.70 Bn | 10.56 Bn |
| 3 | Merck | 364.93 Bn | 357.79 Bn | 12.21 Bn | 12.80 Bn |
| 4 | Novartis Ag | 266.64 Bn | 258.95 Bn | 11.24 Bn | -6.09 Bn |
| 5 | Pfizer | 158.92 Bn | 147.22 Bn | 10.94 Bn | 6.68 Bn |
| 6 | Sanofi | 52.46 Bn | 45.08 Bn | 10.79 Bn | -5.98 Bn |
| 7 | Revolution Medicines | 44.36 Bn | 44.36 Bn | - | 505.13 Mn |
| 8 | Incyte | 25.34 Bn | 20.81 Bn | 1.57 Bn | 976.14 Mn |
| 9 | United Therapeutics | 21.44 Bn | 18.77 Bn | 683.80 Mn | 452.50 Mn |
| 10 | Incannex Healthcare | 41.31 Mn | 41.31 Mn | - | 4.05 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 4.05 Mn |
| Dec 31, 2025 | 7.00 Mn |
| Sep 30, 2025 | 6.79 Mn |
| Jun 30, 2025 | 7.53 Mn |
| Mar 31, 2025 | 5.00 Mn |
| Dec 31, 2024 | 5.02 Mn |
| Sep 30, 2024 | 6.33 Mn |
| Jun 30, 2024 | 9.76 Mn |
| Mar 31, 2024 | 7.42 Mn |
| Dec 31, 2023 | 7.98 Mn |
| Sep 30, 2023 | 4.89 Mn |
| Jun 30, 2023 | 4.19 Mn |
| Mar 31, 2023 | 3.65 Mn |
| Dec 31, 2022 | 3.64 Mn |